A detailed history of Harvest Investment Services, LLC transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Harvest Investment Services, LLC holds 22,978 shares of TGTX stock, worth $771,831. This represents 0.28% of its overall portfolio holdings.

Number of Shares
22,978
Holding current value
$771,831
% of portfolio
0.28%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 15, 2025

BUY
$27.67 - $42.99 $635,801 - $987,824
22,978 New
22,978 $906,000
Q2 2023

Aug 11, 2023

BUY
$15.48 - $35.0 $57,926 - $130,970
3,742 Added 9.19%
44,471 $1.1 Million
Q1 2023

May 15, 2023

BUY
$10.23 - $19.34 $416,657 - $787,698
40,729 New
40,729 $612,000

Others Institutions Holding TGTX

About TG THERAPEUTICS, INC.


  • Ticker TGTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 145,274,000
  • Market Cap $4.88B
  • Description
  • TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...
More about TGTX
Track This Portfolio

Track Harvest Investment Services, LLC Portfolio

Follow Harvest Investment Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Harvest Investment Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Harvest Investment Services, LLC with notifications on news.